At approximately 11:30 p.m., a 32-year-old neurosurgery resident sustained a scalpel cut on the tip of his left fifth finger during an emergency brain surgery involving a patient with HIV. The scalpel had visible blood on it prior to the surgeon sustaining the cut. The scalpel injury occurred about 30 minutes into a complex surgery estimated to last 4 to 5 hours total. The source patient is taking bictegravir-tenofovir alafenamide-emtricitabine, but no recent results for an HIV RNA level are available. The surgeon scrubs out of the case and thoroughly washes the scalpel injury wound with soap and water. The scalpel cut on the finger is shallow but approximately 0.5 cm long; initial bleeding is stopped after pressure is applied to the wound.
What is the best next action regarding HIV occupational postexposure prophylaxis (PEP) for this surgeon?
Figure 1 (Image Series). Effectiveness of Tenofovir Postexposure Prophylaxis in Macaques
Abbreviations: SIV = simian immunodeficiency virus; PEP = postexposure prophylaxis; TFV = tenofovir
In this study, investigators inoculated 24 macaques intravenously with very high-titer simian immunodeficiency virus (SIV). Four animals received placebo postexposure prophylaxis. The remaining 20 animals received postexposure prophylaxis with subcutaneous tenofovir (TFV), beginning at either 24, 48, or 72 hours after the exposure; the duration of the tenofovir was either 3, 10, or 28 days. Note that tenofovir is (R)-9-(2-phosphonylmethoxypropyl) adenine [PMPA].
In this study, investigators inoculated 24 macaques intravenously with very high-titer simian immunodeficiency virus (SIV). Four animals received placebo postexposure prophylaxis. The remaining 20 animals received postexposure prophylaxis with subcutaneous tenofovir (TFV), beginning at either 24, 48, or 72 hours after the exposure; the duration of the tenofovir was either 3, 10, or 28 days. Note that tenofovir is (R)-9-(2-phosphonylmethoxypropyl) adenine [PMPA].
Source: Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol. 1998;72:4265-73.
Figure 1B. Study Results
Abbreviations: SIV = simian immunodeficiency virus
As shown in this graphic, all 4 placebo-treated macaques became infected with SIV. The best outcome occurred with the animals that started tenofovir at 24 hours and received a total of 28 days of therapy.
As shown in this graphic, all 4 placebo-treated macaques became infected with SIV. The best outcome occurred with the animals that started tenofovir at 24 hours and received a total of 28 days of therapy.
Source: Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol. 1998;72:4265-73.
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
December 3rd, 2025
December 3rd, 2025
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine Edurant